IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
-$87.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
198
New
Increased
Reduced
Closed

Top Buys

1
+$17.1M
2
+$8.3M
3
+$6.55M
4
CLDX icon
Celldex Therapeutics
CLDX
+$5.75M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$5.39M

Top Sells

1
+$11.5M
2
+$7.89M
3
+$6.85M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.66M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$6.2M

Sector Composition

1 Healthcare 97.45%
2 Consumer Staples 0.57%
3 Technology 0.57%
4 Financials 0.21%
5 Real Estate 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
$191K 0.03%
27,551
-250,000
127
$187K 0.03%
22,934
-12,500
128
$183K 0.03%
1,283
129
$156K 0.02%
10,785
-31,927
130
$152K 0.02%
49,843
131
$138K 0.02%
227
132
$138K 0.02%
+6,667
133
$104K 0.02%
+323
134
$103K 0.02%
3,807
135
$79K 0.01%
31,029
136
$72K 0.01%
34,131
137
$56K 0.01%
+5,180
138
$50K 0.01%
8,113
139
$44K 0.01%
1,500
-50,000
140
$42K 0.01%
1,765
-280,000
141
$37K 0.01%
603
142
$35K 0.01%
+1,990
143
$28K ﹤0.01%
+3,495
144
$25K ﹤0.01%
+1,500
145
$21K ﹤0.01%
68
146
$9K ﹤0.01%
941
-72,177
147
$5K ﹤0.01%
+52
148
$2K ﹤0.01%
+14
149
$2K ﹤0.01%
+93
150
– –
0
4 5
6
7 8